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Background: With recent advances in post-operative care and surgical methods, the number of cardiovascular
re-operations is increasing. We analyzed our institutional experience to evaluate the safety and efficacy of the
approach methods for cardiac re-operations.
Methods: Between September 2007 and December 2010, we performed 208 cardiac re-operations, defined as
surgery which was not performed within a month from the previous operation or during the same hospitalization
for the same disease and reviewed retrospectively. According to the surgical approach, we divided patients into
two groups: median sternotomy group (S-group, n = 146), and thoracotomy group (T-group, n = 62).
Results: There were no differences in sex or mean interval from the first surgery to re-operation between the two
groups. Mean cardiopulmonary bypass, adhesion dissection time, bleeding control time, and operation time were
significantly shorter in the T-group. The need for transfusion (p = 0.001) during adhesion dissection and the chest
tube drainage (p < 0.001) were significantly lower in the T-group. There were 10 operative deaths in the S-group
(6.8%) and 5 in the T-group (8.1%) (p = 0.757). Pneumonia was the most common cause of death in both groups.
Post-operative bleeding did not result in death and there were no cases of wound infection in the T-group.
Conclusions: Two approaches for repeated cardiac surgery were safe and effective in terms of mortality, wound
infection, bleeding, operation time, adhesion dissecting time, and bleeding control time. We were able to obtain a
good visual field and perform safe surgery by applying the thoracotomy method in selective patients for
cardiovascular re-operation.
Keywords: Reoperation, Sternotomy, ThoracotomyBackground
With recent advances in post-operative care and surgical
methods, the number of cardiovascular re-operations is
increasing. The traditional median sternotomy is com-
monly considered the standard and popular approach
for cardiovascular re-operation. However, when re-
operations are performed through median sternotomy,
problems unrelated to the underlying heart disease can
occur, such as damage to the cardiac structure, pro-
longed duration of cardiopulmonary bypass, and
increased need for blood transfusion [1-3]. The thoracot-
omy approach has been applied to avoid these risks, and
recent studies showed that the thoracotomy approach
for repeat cardiac surgery may decrease risks associated
with cardiac surgery and improve early outcomes [4,5].* Correspondence: cheehk@kuh.ac.kr
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reproduction in any medium, provided the orTo address these issues, we analyzed our institutional
experience to evaluate the safety and efficacy of two ap-
proach methods for cardiac re-operations.
Methods
Patients
Between September 2007 and December 2010, we per-
formed 208 cardiac re-operations, defined as surgery
which was not performed within a month from the pre-
vious operation or during the same hospitalization for
the same disease and reviewed retrospectively. Mean age
at re-operation was 59.0 ± 17.0 years; 91 patients were
male and 117 were female. Mean interval from the first
surgery to re-operation was 144.0 ± 113.0 months (me-
dian 119.7 months). One hundred seventy-one patients
underwent a second operation, 28 patients had a third oper-
ation, and 9 patients had 4 or more operations. According to
the surgical approach, we divided patients into two groups:
median sternotomy group (S-group, n = 146), and thoracot-
omy group (T-group, n = 62). Only right thoracotomy wasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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our institutional review board (No.: 1080015), and the re-
quirement of informed consent was waived by the board
owing to the retrospective nature of the study.
Table 1 reports reasons for re-operation. In the S-group,
there were 68 cases of valvular heart disease, 33 con-
genital heart disease (pulmonary regurgitation after re-
pair of tetralogy of Fallot in 25, residual shunt through
ventricular septal defect in 2, others in 6), 21 aortic dis-
ease, 15 coronary artery disease, 3 dilated cardiomyop-
athy, and 6 other diseases. In the T-group, there were 59
cases of valvular heart disease, 2 congenital heart dis-
ease (residual shunt through atrial septal defect), and 1
other disease (Table 1).
All patients except emergency cases underwent chest
computed tomography to evaluate adhesion.
Definition
Operation time was defined as the time from skin inci-
sion to skin closure. From the time of skin incision to
the time of heparin injection was considered as the time
of adhesion dissection. The interval between discontinu-
ation of cardiopulmonary bypass and skin closure was
regarded as the time of bleeding control.
Surgical method
Our approach in cardiac re-operations is as follows.
Right thoracotomy was performed on patients who
needed re-operation due to atrioventricular valve dis-
eases and/or residual shunt through atrial septal defect.
Median sternotomy was performed for the patients with
valvular heart disease including the aortic valve and/or
aortic disease. We also performed the cardiac re-
operation through median sternotomy when we could
not gain an adequate approach via thoracotomy, such as
pulmonary valve replacement after repair of tetralogy of






Aortic valve 33 0 33
Mitral valve 12 27 39
Tricuspid valve 1 19 20




Congenital 33 2 35
Aorta 21 0 21
Coronary 15 0 15
DCMP 3 0 3
Others 6 1 7
Abbreviation: MV, mitral valve; DCMP, dilated cardiomyopathy.In case of thoracotomy, we most commonly used the
femoral artery, vein, and the right internal jugular vein
as vascular access for cardiopulmonary bypass. The can-
nula through the right internal jugular vein was inserted
percutaneously before beginning the operation. We used
DLP cannulas (17 – 21 Fr. for artery, 21–24 Fr. for vein,
Medtronic Inc., MN, USA) for femoral cannulation and
RMI 20Fr. cannula (Edward’s lifescience LLC, Irvine,
CA) for internal jugular cannulation. Thoracotomy was
performed through the fourth intercostal space; the fem-
oral artery and vein were prepared simultaneously. For
female patients, skin incision was made along the crease
line underneath the breast. A root cannula for infusion
of cardioplegia and air ventilation was inserted in the
ascending aorta. If a patient had patent grafts on the
ascending aorta, we performed the surgery without aor-
tic cross-clamp under fibrillatory arrest.
Median sternotomy was performed in the usual man-
ner. We commonly used the ascending aorta, superior
vena cava and inferior vena cava as vascular access for
cardiopulmonary bypass. In case of severe adhesion be-
tween the mediastinum and the heart, we used the fem-
oral artery and vein and superior vena cava as vascular
access after we dissected adhesion as far as possible. If a
patient had patent grafts on the ascending aorta, we per-
formed aortic cross-clamp higher than level of the graft.
Statistics
Data are presented as frequencies, or means with stand-
ard deviations. For the comparisons of patient character-
istics between groups, student T-test was performed for
continuous variable and chi-square test for categorical
variables. A p value of 0.05 or less was considered sig-
nificant. SPSS version 17 (Korean version) was used for
statistical analysis.
Results
Patient profiles and operation profiles were summarized
in Table 2. Mean age at re-operation was younger in the
S-group than the T-group (p = 0.004). There were no dif-
ferences in sex or mean interval from the first surgery to
re-operation between groups. Excluding 8 patients had
undergone re-operation without cardiopulmonary by-
pass, the remaining 200 patients had a mean of 182 ±
94 minutes for the cardiopulmonary bypass. In the
entire cohort, mean aortic cross clamping time was
113 ± 56 minutes, mean adhesion dissection time was
165 ± 63 minutes, mean bleeding control time was 130 ±
73 minutes, and mean operation time was 470 ±
160 minutes. T-group had shorter cardiopulmonary by-
pass time (p < 0.001), adhesion dissection time (p < 0.001),
bleeding control time (p = 0.009) and operation time
(p < 0.001). However, there was no difference in aortic
cross clamping time (p = 0.069). In the T-group the
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adhesion dissection was significantly lower than in the S-
group (p = 0.001). Chest tube drainage in the first 8 hrs was
statistically lower in the T-group (p < 0.001).
There were 10 operative deaths in the S-group and 5
in the T-group. Causes of deaths were summarized in
Figure 1. In the S-group, infections were most common
cause of death. In the T-group, infections were also most
common cause of death. Details of complications were
summarized in Table 3. There were 23 complications over-
all. There were no differences between groups (p = 0.783).
In the S-group, post-operative bleeding was most common
complication. In the T-group, post-opeartive bleeding was
also most common complication.
In the T-group, all patients underwent peripheral can-
nulation using the femoral artery, vein and internal
jugular vein for cardiopulmonary bypass. In the S-group,
46 patients underwent peripheral cannulation using the
femoral artery and vein and superior vena cava and the
others underwent central cannulation using the ascend-
ing aorta, superior vena cava and inferior vena cava for
cardiopulmonary bypass. In the T-group, we did not
perform aortic cross-clamp in 2 patients who under-
went mitral valve surgery because of previously grafted
vessels.32 patients underwent re-operation due to re-
curred tricuspid regurgitation. Ten patients were oper-
ated on via median sternotomy; the remaining 22
patients were approached by a right thoracotomy. There
were no operative deaths in the S-group but four
(12.5%) in the T-group.
Discussion
The present study shows that both approach methods
for cardiac re-operation show no significant differencesTable 2 Patient profiles and operation profiles
Sternotomy gro
Age, years 45.9 ± 18.0
Sex(M/F), n 75/71
Operation interval, months 136.2 ± 117.0
Operation time, minutes 502 ± 169
ACC time, minutes 119 ± 60
CPB time, minutes 199 ± 99
Adhesion dissection time, minutes 177 ± 67
Bleeding control time, minutes 139 ± 83
Mortality rate,%(n) 6.8% (10/146)∮
Hctind,% 35.8 ± 4.6
HctpreCPB,,% 33.2 ± 5.0
RBC trasfusion, packs (1 pack = 400 ml) 0.5 ± 1.2
Chest tube drainage(8 hrs), ml 466.2 ± 413.4
Abbreviation: M, male; F, female; ACC, aortic cross clamp; CPB, cardiopulmonary byp
just before the cardiopulmonary bypass institution; RBC, red blood cell.in rates of operative mortality, post-operative bleeding,
or cerebrovascular accidents. There was no cases of
wound infection in the T-group. In this study, we
included a variety of cardiac diseases and divided
patients into two groups based on surgical approach. In
order to evaluate the safety and efficacy of the approach
methods, we only evaluated early results such as mortal-
ity and morbidity, because long-term follow-up results
are more related to the underlying cardiac disease. For
this reason we did not include long-term follow-up data.
Many re-operations are performed at sites of previous
surgery. Deciding on the area of incision is of import-
ance considering not only the surgery itself but also
early outcome. The median sternotomy approach is
commonly used for re-operation due to the advantage of
a superior visual field. However, it carries an increased
risk of ventricular rupture, brachial plexus damage from
fracture of the first rib, and innominate vein injury. In
the S-group, we instituted cardiopulmonary bypass after
adhesion dissection to reduce the cardiopulmonary by-
pass time, but we performed peripheral cannulation
before finishing adhesion dissection to avoid disastrous
outcomes in 46 cases that had severe adhesion between
the mediastinum and the heart. A unilateral thoracot-
omy approach minimizes peeling and dissection of adhe-
sions in the surgical area, avoiding some of the risks
associated with median sternotomy. There were 9 post-
operative bleeding (4.3%) in the entire study population,
with no significant difference between two groups. Oper-
ation time, cardiopulmonary bypass time, adhesion dis-
section time and bleeding control time were shorter in
the T-group than the S-group. The need for transfusion
during adhesion dissection and the chest tube drainage
were significantly lower in the T-group. These resultedup Thoracotomy group P value
53.4 ± 14.8 0.004
16/46 0.001
162.2 ± 101.4 0.13
395 ± 106 <0.001
100 ± 37 0.069
144 ± 68 <0.001
138 ± 44 <0.001
110 ± 35 0.009
8.1% (5/62)∮ 0.757
35.8 ± 4.4 0.919
34.4 ± 4.7 0.103
0.1 ± 0.5 0.001
312.1 ± 199.2 <0.001
ass; Hctind, hematocrit just after anesthesia induction; . HctpreCPB, hematocrit
Operation 
Ascednding aorta and aortic 
arch replacement (5) 
Heart transplantation (2) 





TAP (4) Thoracotomy 
group (5) MVR (1) 










Figure 1 Causes of mortality.
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ever, the thoracotomy approach can only be applied in a
limited number of cases, and conversion to median ster-
notomy will sometimes be required. To avoid this, we
used the thoracotomy approach in selective cases. A
right anterolateral thoracotomy approach was performed
only in case of atrioventricular valve diseases or/and
atrial septal defect.
In the T-group, we underwent one mitral valve re-
placement and one mitral valve repair without aortic
cross-clamp. One patient had a previously grafted saphe-
nous vein on the ascending aorta and the other had a
previously grafted radial artery on the ascending aorta.
As Umakanthan et al. reports the safety and reproduci-
bility of clampless technique [6], we decided not to
clamp the ascending aorta and open the left atrium as
soon as possible after fibrillation. We also inserted a vent
into the left ventricle and injected carbon dioxide con-
tinuously during the surgery. We successfully removed
the air through root vent and weaned cardiopulmonary
bypass. After the surgery, patient weaned ventilator






Total, n (%) 17 (11.6) 6(9.7) 0.783




Infections, n 4 0
Cerebrovascular accident, n 2 2For cardiac re-operation, the reported mortality rate is
8–12.5% and post-operative bleeding rate is 2–4%
[5,7-10]. We found a similar mortality rate. The most
common cause of death was pneumonia in both groups.
Bleeding was the second common cause of death in the
S-group, but not in the T-group. There were three cases
of post-operative bleeding, but these did not result in
death in the T-group. In this study, 32 patients under-
went cardiac re-operation for recurred tricuspid regurgi-
tation. Given the high mortality rate of re-operation for
recurred tricuspid regurgitation (up to 37%) [11,12], we
believe that the mortality rate (7.2%) was not high com-
pared to the previous studies.
Limitations
This study is subject to the limitations inherent in retro-
spective work with observational data. There were no
matched patients between the S-group and T-group,
which caused difficulty in performing a simple compari-
son study. There was a limited number of operable
valves and congenital heart diseases approachable
through thoracotomy.
Conclusions
Mortality and morbidity rates were favorable in both
groups. Pneumonia was the most common cause of
death in both groups. Re-operative approaches, thoracot-
omy and median sternotomy, for various cardiac
diseases were safe and effective in terms of mortality,
wound infection, bleeding, operation time, adhesion dis-
secting time, and bleeding control time. We were able to
obtain a good visual field and perform safe surgery by
applying the thoracotomy method in selective patients
for cardiovascular re-operation.
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